Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00417651
Other study ID # 2006H0078
Secondary ID
Status Completed
Phase Phase 1
First received January 2, 2007
Last updated December 13, 2011
Start date July 2006
Est. completion date October 2007

Study information

Verified date December 2011
Source Ohio State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to evaluate whether creating a gastrotomy (hole in the stomach) during gastric surgery increases a patient's risk of intra-abdominal infection.

We hypothesize that a gastrotomy does not contaminate the abdomen with clinically significant bacterial pathogens.


Description:

We propose to investigate the bacterial load and contamination patients experience during laparoscopic roux-en-y gastric bypass while having their gastrotomy for gastrojejunostomy. In all patients who undergo laparoscopic roux-en-y gastric bypass, the stomach must be opened to the peritoneal cavity while placing an anvil for gastrojejunostomy.

Samples of gastric fluid will be collected and sent for analysis in all patients. Samples of peritoneal fluid will be collected prior to and after the creation of the gastrotomy, using intraperitoneal irrigation with approximately 500 cc of normal saline. Bacterial counts and identification will be recorded for each sample.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 2007
Est. primary completion date October 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- any patient undergoing roux-en-y gastric bypass

Exclusion Criteria:

- lack of consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States The Ohio State University Center for Minimally Invasive Surgery Columbus Ohio

Sponsors (1)

Lead Sponsor Collaborator
Jeffrey Hazey

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quantitative and qualitative measure of the bacterial load and bacterial contamination of the abdomen during laparoscopic roux-en-y gastric bypass surgery while the gastrotomy is open to the abdominal cavity.
See also
  Status Clinical Trial Phase
Recruiting NCT05759689 - Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery N/A
Completed NCT00929461 - Impact of Omega-3 Fatty Acids on Lactate N/A